Precipio Announces Commercial Launch of COVID-19 Antibody Test
30. Juli 2020 10:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 30, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), is announcing its COVID-19 strategy, and its intent to contribute to the battle...
Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q1’20
22. Juli 2020 10:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 22, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced its preliminary unaudited revenues for its pathology services increased...
Precipio Regains Listing Compliance with NASDAQ Minimum Bid Requirement
01. Juli 2020 14:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 01, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has regained compliance with the Nasdaq listing requirements. On...
Precipio Adds Another HemeScreen™ Customer
09. Juni 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 09, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that Cancer and Hematology Centers of Western Michigan (CHCWM) has adopted...
Q1-2020 Net Revenues increase 77% over Q4-2019 to $1.2M
15. Mai 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 15, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its form 10Q for the period ending March 31st, 2020. Within the report,...
Precipio Announces Q1-2020 Corporate Update Call For Shareholders
12. Mai 2020 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 12, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Quarter1-2020 corporate update call on Tuesday, May 19th at...
Precipio Launches New HemeScreen™ Reagent Rental Program
06. April 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 06, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ Reagent Rental (HSRR) program....
Company Update During the COVID-19 Era
20. März 2020 09:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 20, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), released today the following letter to shareholders from its CEO, Ilan Danieli. ...
Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division
16. März 2020 09:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 16, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has completed the non-cash transaction of the transition of...
Precipio achieves impressive initial results of Artificial Intelligence Decision-Support Tool
26. Februar 2020 11:30 ET
|
Precipio, Inc.
Groundbreaking clinical and economic impact to be generated NEW HAVEN, Conn., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that...